Please be aware that this event has been cancelled.
Explore FAQs (Frequently Asked Questions) for the Inaugural Multi-Omics Based Drug Discovery & Development Summit
What is the Multi-Omics Based Drug Discovery & Development Summit?
As biopharma’s only event focused specifically on multi-omics, this meeting is your roadmap to optimizing data integration and large-scale analysis to enable multi-omics insights across therapeutic development.
Focusing on genomics, epigenomics, transcriptomics, proteomics, metabolomics, and beyond, this summit will unite biopharma experts and KOLs to address key multi-omics data challenges and exemplify how to apply multi-omics from target discovery to patient stratification.
Why Has This Meeting Been Created?
Multi-omics is rapidly gaining attention as an innovative way of delving deeper into pathology and disease mechanisms to inform drug development decisions. Enhanc3d Genomics recently launched a suite of 3D multi-omic solutions to accelerate drug development, Evotec and QIAGEN have entered a software collaboration for enhanced multi-omics data insights, and GSK has partnered with multi-omics AI company Relation in a £45million deal.
Leading industry players understand the immense potential of multi-omics for maximizing the efficiency of pipeline progression. Amongst the building excitement, this Summit will support omics experts to optimize data analysis and achieve new multi-omics applications.
Who Can I Expect To Meet?
A diverse range of biopharma decision makers and scientists working across different modalities and indications are uniting at this meeting, as well as leading academics pioneering omics methodologies.
From Arda Therapeutics to Amgen, BPGBio to Boehringer Ingelheim, take a look at our expert speaker faculty sharing cutting-edge multi-omics data.
Why Should I Attend As a Delegate?
Across 2 days, learn the data integration, storage and analysis strategies of biopharma experts who have successfully implemented multi-omics into their workflows. With panel discussions, round table sessions and plenty of networking opportunities, this forum will connect you with other experts to brainstorm innovative solutions to multi-omics challenges.
Hear data-driven case studies on novel target identification and informed precision medicine development made possible through the unique insights multi-omics brings, so you can effectively conduct large-scale multi-omics analysis and transform your pipeline progression.
Why Should I Attend As a Partner?
Uniting 60+ biopharma experts and KOLs from pioneering labs, this summit is your opportunity to connect with a diverse range of decision makers who are looking for support with omics methodologies and analysis, ML data capabilities, databases and visualisation platforms and tissue sourcing and processing.
Whether you prefer to share your data in front of an audience, converse over a coffee or showcase your services at an exhibition booth, there are plenty of ways to connect with this targeted multi-omics audience.